Search Press releases Keywords From To 14 Jun 2015 Positive results from Phase 3 study evaluating CIMZIA® (certolizumab pegol) in DMARD-naïve rheumatoid arthritis patients Read More 9 Jun 2015 UCB demonstrates scientific excellence with multiple presentations from immunology portfolio at EULAR 2015 Read More 8 Jun 2015 UCB announces submission of Kremers Urban's methylphenidate HCl ER bioequivalence study results to FDA Read More 30 Apr 2015 UCB's shareholder meeting today Read More 30 Apr 2015 UCB Interim Report for the first three months of 2015: Read More 29 Apr 2015 Acquisition of own shares (April 29) Read More Pagination First page Previous page Previous … Page 97 Page 98 Page 99 Page 100 Current page 101 Page 102 Page 103 Page 104 Page 105 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
